April 17, 2012
Avion Pharmaceuticals, LLC, a specialty pharmaceutical company focused in Women’s Health, recently announced the appointment of Michael Sullivan as Vice President, Sales and Marketing. Sullivan will be responsible for all sales and marketing efforts for Avion. Avion Pharmaceuticals recently re-launched the PRENATE® FAMILY of prenatal vitamins, newly reformulated with QUATREFOLIC®, the fourth generation of folic acid.
Sullivan has more than 20 years of successful prescription pharmaceutical sales and marketing experience, including “start-up” expertise.
Mike is a graduate of Neumann University and he earned his Master’s in Business Administration from Frostburg State University.
“We are thrilled to have Mike’s expertise in the Women’s Healthcare category as we build our PRENATE® franchise,” said Mark Pugh, CEO of Avion Pharmaceuticals. “We are looking to Mike to assist us in expanding into other therapeutic categories and advancing our brand presence in the prescription market.”
Avion is a specialty pharmaceutical company that develops and markets a growing portfolio of innovative, branded pharmaceutical and dietary supplement products in the Women’s Health and Dermatology areas. Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available dietary supplement products, therapeutics and late –stage development drugs to fulfill unmet medical and dietary needs.